Germany – Pharmaceutical products – Arzneimittelvergaben Biosimilare 01.07.2026
closedValue
unstated
Published
30 Dec 2025
Deadline
—
Type
opportunity · framework
33600000 · Medical equipment, pharmaceuticals & personal care
Description
Beschaffung des Arzneimittels 'Aflibercept 2 mg Injektionslösung Durchstechflasche St' für einen beabsichtigten Vertragsstart am 01.07.2026 und einen noch festzulegenden Zeitraum.
Key facts
- Procedure
- neg-w-call
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Submit via
- https://vergabe.pbmg.eu/
- Contact
- pbmg@pbmg.org
- Contract period
- 1 Jul 2026 → …
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 867817-2025
- First seen
- 22 Aug 2026
- Last updated
- 28 Aug 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/49775d62-7588-4bf1-a975-64516316f233The source notice is authoritative — verify deadlines and documents there before bidding.